Aragen Bioscience

ANTIBODY DISCOVERY

Experts in antigen design and hybridoma development.

In-depth experience from gene synthesis and subcloning to protein expression and purification.

Proven track record for a broad range of in vitro and in vivo models of disease.

Short timelines and high titers at every development stage with CLD services.

IPF Summit
August 27-29
San Diego

Visit our booth and join us for a presentation by Pharmaxis.

New Resources

Download our new capabilities brochure!

…the data they have generated has been used in regulatory filings to enable clinical trials and has informed our clinical indications…
Hector M Rodriguez, PhD, Hector M Rodriguez, previously head of Analytical Biochemistry, Arresto Biosciences. Currently VP of Biology, BridgeBio Pharma

GVK BIO announces the appointment of Axel Schleyer, Ph.D. as Chief Executive Officer, Aragen Bioscience, Inc.

Aragen Bioscience Expands Cell Line Development Services

11.10.2017
Aragen Bioscience Announces AAALAC Accreditation